Human anti-V2 monoclonal antibody that neutralizes primary but not laboratory isolates of human immunodeficiency virus type 1.

Por Gorny, M K, Moore, J P, Conley, A J, Karwowska, S, Sodroski, J, Williams, C, Burda, S, Boots, L J, Zolla-Pazner, S
Publicado em 1994

Neutralization of divergent human immunodeficiency virus type 1 variants and primary isolates by IAM-41-2F5, an anti-gp41 human monoclonal antibody.

Por Conley, A J, Kessler, J A, Boots, L J, Tung, J S, Arnold, B A, Keller, P M, Shaw, A R, Emini, E A
Publicado em 1994

A vaccine-elicited, single viral epitope-specific cytotoxic T lymphocyte response does not protect against intravenous, cell-free simian immunodeficiency virus challenge.

Por Yasutomi, Y, Koenig, S, Woods, R M, Madsen, J, Wassef, N M, Alving, C R, Klein, H J, Nolan, T E, Boots, L J, Kessler, J A
Publicado em 1995

Neutralization of primary human immunodeficiency virus type 1 isolates by the broadly reactive anti-V3 monoclonal antibody, 447-52D.

Por Conley, A J, Gorny, M K, Kessler, J A, Boots, L J, Ossorio-Castro, M, Koenig, S, Lineberger, D W, Emini, E A, Williams, C, Zolla-Pazner, S
Publicado em 1994

A human monoclonal antibody to a complex epitope in the V3 region of gp120 of human immunodeficiency virus type 1 has broad reactivity within and outside clade B.

Por Moore, J P, Trkola, A, Korber, B, Boots, L J, Kessler, J A, McCutchan, F E, Mascola, J, Ho, D D, Robinson, J, Conley, A J
Publicado em 1995

The consequence of passive administration of an anti-human immunodeficiency virus type 1 neutralizing monoclonal antibody before challenge of chimpanzees with a primary virus isola...

Por Conley, A J, Kessler JA, I I, Boots, L J, McKenna, P M, Schleif, W A, Emini, E A, Mark, G E, Katinger, H, Cobb, E K, Lunceford, S M, Rouse, S R, Murthy, K K
Publicado em 1996